Polypharmacy, potentially inappropriate medications, and chemotherapy-related adverse events among older adults with cancer.
Ronald J. Maggiore, Arti Hurria(Unknown), Heidi D. Klepin(Wake Forest University), Ajeet Gajra(Pinnacle Clinical Research), Reena Jayani(Vanderbilt University Medical Center), Supriya G. Mohile(University of Rochester Medical Center), William P. Tew(Memorial Sloan Kettering Cancer Center), Stuart M. Lichtman(Memorial Sloan Kettering Cancer Center), Vani Katheria(City of Hope), Jeremiah R. Brown(Dartmouth College), CP Gross, Molly Hardt, Rupal Ramani, Cynthia Owusu
Cited by 11
Related Papers
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
|Journal of Clinical Oncology|2011|1.8k
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
|Journal of Clinical Oncology|2015|1k
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
|CA A Cancer Journal for Clinicians|2015|737